LOS
ANGELES, Nov. 3, 2022 /PRNewswire/ -- Aadi
Bioscience, Inc. (NASDAQ: AADI), a commercial-stage
biopharmaceutical company focused on developing and commercializing
precision therapies for genetically-defined cancers with
alterations in mTOR pathway genes, today announced that the Company
will be presenting and hosting one-on-one meetings at the following
conferences during November:
- H.C. Wainwright 3rd Annual Precision Oncology
Virtual Conference, November 14,
2022
-
- Neil Desai, Ph.D., Aadi
Bioscience Founder and CEO, will participate in a fireside chat
with the banking equity analyst, available on demand to registered
conference attendees
- Jefferies London Healthcare Conference, November 15-17, 2022, in London
-
- Neil Desai, Ph.D., Aadi
Bioscience Founder and CEO, and Brendan
Delaney, Aadi Bioscience COO, will take part in a hybrid
presentation including a moderated Q&A session on Tuesday,
November 15th, at 3:35 am
ET (8:35 am GMT)
- Piper Sandler 34th
Annual Healthcare Conference, November
29-December 1, 2022, in New
York
-
- Dr. Desai and Mr. Delaney will participate in a fireside chat
with the equity analyst on Wednesday, November 30, 2022 at
12:30 pm ET
Replays of webcasts will be available on IR pages of the Aadi
Biosciences website for approximately 30 days following each
presentation.
About Aadi Bioscience,
Inc.
Aadi is a commercial-stage biopharmaceutical company focused on
precision therapies for genetically defined cancers to bring
transformational therapies to cancer patients with mTOR pathway
driver alterations. Aadi received FDA approval in November of 2021
and in February of 2022 commercialized FYARRO® for the treatment of
adult patients with locally advanced unresectable or metastatic
malignant perivascular epithelioid cell tumor (PEComa).
Aadi has also initiated PRECISION 1, a Phase 2 tumor-agnostic
registration-intended trial in mTOR inhibitor-naïve malignant solid
tumors harboring TSC1 or TSC2 inactivating
alterations. More information on the Company's development pipeline
is available on the Aadi website at www.aadibio.com and
connect with us
on Twitter and LinkedIn.
Contact:
Marcy
Graham
IR@aadibio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aadi-bioscience-to-present-at-upcoming-investor-conferences-301667554.html
SOURCE Aadi Bioscience